FBT
GILD icon

Founders Bank & Trust’s Gilead Sciences GILD Stock Holding History

Founders Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$47K Hold
500
– – 0.02% 184
2014
Q3 		$53K Hold
500
– – 0.03% 175
2014
Q2 		$41K Buy
+500
New +$38.9K 0.02% 186

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Founders Bank & Trust's GILD Position: Q4 2014 in Review

Founders Bank & Trust held its Gilead Sciences (GILD) position steady in Q4 2014 at 500 shares worth $47K. The position accounts for 0.02% of the portfolio, ranked #184.

Founders Bank & Trust first reported a position in GILD in Q2 2014 and has held it in 3 quarters since. The position peaked at $53K in Q3 2014. 1,441 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Founders Bank & Trust held 500 shares of Gilead Sciences worth $47K as of Q4 2014.
  • Founders Bank & Trust left its Gilead Sciences share count unchanged in Q4 2014.
  • Gilead Sciences made up 0.02% of Founders Bank & Trust's portfolio in Q4 2014, its #184 holding.
  • Founders Bank & Trust first reported a position in Gilead Sciences in Q2 2014 and has held it in 3 quarters since.
  • Founders Bank & Trust's Gilead Sciences position peaked at $53K in Q3 2014.
  • 1,441 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.